S
Sohee Kim
Researcher at Korea University
Publications - 44
Citations - 1567
Sohee Kim is an academic researcher from Korea University. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 15, co-authored 36 publications receiving 1218 citations.
Papers
More filters
Journal ArticleDOI
Open versus laparoscopic surgery for mid-rectal or low-rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): survival outcomes of an open-label, non-inferiority, randomised controlled trial.
Seung-Yong Jeong,Seung-Yong Jeong,Ji Won Park,Ji Won Park,Byung-Ho Nam,Sohee Kim,Sung Bum Kang,Seok Byung Lim,Hyo Seong Choi,Duck Woo Kim,Hee Jin Chang,Dae Yong Kim,Kyung Hae Jung,Tae You Kim,Gyeong Hoon Kang,Eui Kyu Chie,Sun-Young Kim,Dae Kyung Sohn,Dae-Hyun Kim,Jae Sung Kim,Hye Seung Lee,Jee Hyun Kim,Jae Hwan Oh +22 more
TL;DR: The results show that laparoscopic resection for locally advanced rectal cancer after preoperative chemoradiotherapy provides similar outcomes for disease-free survival as open resection, thus justifying its use.
Journal ArticleDOI
Laparoscopy-assisted versus Open D2 Distal Gastrectomy for Advanced Gastric Cancer: Results From a Randomized Phase II Multicenter Clinical Trial (COACT 1001).
Young-Kyu Park,Hong Man Yoon,Young-Woo Kim,Ji Yeon Park,Keun Won Ryu,Young-Joon Lee,Oh Jeong,Ki Young Yoon,Jun Ho Lee,Sang Eok Lee,Wansik Yu,Sang-Ho Jeong,Taebong Kim,Sohee Kim,Byoung-Ho Nam +14 more
TL;DR: LADG was feasible for AGC treatment based on the noncompliance rate of D2 lymph node dissection, and subgroups analysis data suggest that further studies are needed for stage III gastric cancer.
Journal ArticleDOI
Risk for leptomeningeal seeding after resection for brain metastases: implication of tumor location with mode of resection.
Jun Hyong Ahn,Sang Hyun Lee,Sohee Kim,Jungnam Joo,Heon Yoo,Seung Hoon Lee,Sang Hoon Shin,Ho-Shin Gwak +7 more
TL;DR: It is suggested that piecemeal resection using the CUSA should be limited because of the risk of postsurgical LMS, especially when the tumor is in contact with the CSF pathway.
Journal ArticleDOI
Analysis of Treatment Outcomes of Intraventricular Chemotherapy in 105 Patients for Leptomeningeal Carcinomatosis from Non–Small-Cell Lung Cancer
Ho-Shin Gwak,Jungnam Joo,Sohee Kim,Heon Yoo,Sang Hoon Shin,Ji-Youn Han,Heung Tae Kim,Jin Soo Lee,Seunghoon Lee +8 more
TL;DR: Intraventricular chemotherapy for patients with LMC from non–small-cell lung cancer could palliate associated symptoms and prolong patients’ survival, and careful selection of patients for intraventionricular chemotherapy is recommended with aggressive ICP control and concurrent systemic chemotherapy.
Journal ArticleDOI
Lazertinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer: results from the dose escalation and dose expansion parts of a first-in-human, open-label, multicentre, phase 1–2 study
Myung-Ju Ahn,Ji Youn Han,Ki Hyeong Lee,Sang We Kim,Dong Wan Kim,Yun Gyoo Lee,Eun Kyung Cho,Joo Hang Kim,Gyeong Won Lee,Jong Seok Lee,Young Joo Min,Jin Soo Kim,Sung Sook Lee,Hye Ryun Kim,Min Hee Hong,Jin Seok Ahn,Jong Mu Sun,Heung Tae Kim,Dae Ho Lee,Sohee Kim,Byoung Chul Cho +20 more
TL;DR: Lazertinib had a tolerable safety profile and showed promosing clinical activity in patients with NSCLC progressing on or after EGFR TKI therapy, and the findings provide a rationale for further clinical investigations.